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An emerging infection comes to our attention
because it involves a newly recognized organism,
a known organism that newly started to cause
disease, or an organism whose transmission has
increased. Although Cryptosporidium is not new,
evidence suggests that it is newly spread (in
increasingly used day-care centers and possibly in
widely distributed water supplies, public pools,
and institutions such as hospitals and extended-
care facilities for the elderly); it is newly able to
cause potentially life-threatening disease in the
growing number of immunocompromised patients;
and in humans, it is newly recognized, largely
since 1982 with the AIDS epidemic. Crypto-
sporidium is a most highly infectious enteric
pathogen, and because it is resistant to chlorine,
small and difficult to filter, and ubiquitous in
many animals, it has become a major threat to
the U.S. water supply. This article will focus on the
recognition and magnitude of cryptosporidiosis,
the causative organism and the ease with which it
is spread, outbreaks of cryptosporidiosis infection,
and its pathogenesis, diagnosis, and treatment.
Recognition and Magnitude
of Cryptosporidiosis
First recognized by Clarke and Tyzzer (1) at the
turn of the century and well known to veterinarians,
Cryptosporidium was reported as a human patho-
gen in 1976 by Nime (2). From 1976 until 1982,
seven cases of cryptosporidiosis were reported in
humans, five of which were in immunosuppressed
patients. Since 1982, cryptosporidiosis has been
increasingly recognized as a cause of severe, life-
threatening diarrhea in patients with AIDS as
well as in previously healthy persons (3). Of the
first 58 cases of cryptosporidiosis described in
humans by 1984, 40 (69%) were in immunocompro-
mised patients who contracted severe, often irre-
versible, diarrhea (lasting longer than 4 months in
65%); of these 40 patients, 33 (83%) had AIDS (4-6);
55% of the 40 immunocompromised patients  died.
A review of 78 reports of more than 131,000
patients and more than 6,000 controls showed
Cryptosporidium infection in 2.1% to 6.1% of immuno-
competent persons in industrialized and devel-
oping countries, respectively, vs. 0.2% to 1.5% in
controls (Table 1). A review of an additional 22
reports of nearly 2,000 human immunodeficiency
virus (HIV)-infected persons showed Cryptospori-
dium infection in 14% to 24% of HIV-infected
persons with diarrhea vs. 0% to 5% of HIV-infected
controls without diarrhea (7). Seroepidemiologic
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studies suggest that 17% to 32% of nonimmuno-
compromised persons in Virginia, Texas, and
Wisconsin, as well as nonimmunocompromised
Peace Corps volunteers (before travel), have
serologic evidence of Cryptosporidium infection
by young adulthood. In contrast, more than half
of the children in rural Anhui, China, had
serologic evidence of cryptosporidial infection by
5 years of age, and more than 90% of children
living in an impoverished area of Fortaleza,
Brazil, had serologic evidence of cryptosporidial
infection in their first year of life (Figure) (8-11).
The Organism
Among protozoa, C. parvum is the major
human pathogen that is also found in numerous
mammals. It is slightly smaller than the murine
Cryptosporidium, C. muris, and is also distin-
guished from the other Cryptosporidium species
commonly seen in birds, turkeys, snakes, and fish.
Infection begins when a person ingests  chlorine-
resistant, thick-walled oocysts (7). These hardy
oocysts appear to be infectious, with an estimated
ID50 (from studies in humans) of one isolate con-
taining only 132 oocysts (12). Infections may occur
with ingestion of as few as 30 oocysts; some
infections have occurred with just one oocyst (13).
When the oocysts reach the upper small
bowel, the proteolytic enzymes and bile salts
enhance the excystation of four infectious sporo-
zoites, which enter the brush border surface
epithelium and develop into merozoites capable
of replicating either asexually or sexually beneath
the cell membrane (but extracytoplasmically) in
the brush border epithelial cell surface. Sexual
stages combine to form new oocysts, some of which
(perhaps 20% as thin-walled oocysts) may sporu-
late and continue infection in the same person,
while others (thick-walled oocysts) are excreted.
Although few organisms may enter through M
cells, systemic infection essentially does not occur;
the occasional biliary tract or respiratory tract
infections in immunocompromised patients probably
reached these sites through the lumenal surface.
Cryptosporidiosis Outbreaks
Numerous well-documented outbreaks of
cryptosporidiosis have occurred. Most of these
often waterborne outbreaks have involved subtle
problems in the flocculation and/or filtration pro-
cess (17-21). These outbreaks culminated in the
huge waterborne outbreak in Milwaukee, which
was initially thought to be viral gastroenteritis,
reported to the State Health Department on
April 5, 1993, diagnosed on April 7, and followed
by an advisory note that evening to the public to
boil all drinking water (Table 2). This became the
largest waterborne outbreak in U.S. history and
affected an estimated 403,000 persons, thus con-
stituting a 52% attack rate among those served
by the South Milwaukee water works plant.
Several immunocompromised patients died, and
many previously healthy persons became ill. The
mean duration of illness was 12 days with a range
of 1 to 55 days, and the average maximum number
of watery diarrheal stools was 19 per day at the
peak of illness. While watery diarrhea was the
predominant symptom among 93% of confirmed
Table 1. Rates of Cryptosporidium infection among
immunocompetent and HIV-positive persons in
industrialized and developing areasabc
Patients Controls
with diarrhea without diarrhea
Immuno-
competent
Industr. 2.2%(0.26%-22%) 0.2%(0%-2.4%)
 areas [n=2232/107,329] [n=3/1941]
Developing 6.1%(1.4%-40.9%) 1.5% (0%-7.5%)
 areas [n=1486/24,269] [n=61/4146]
HIV-positive
Industr. 14%(6%-70%) 0%(0%-0%)
 areas [n=148/1074] [n=0/35]
Developing 24%(8.7%-48%) 5%(4.9%-5.3%)
 areas [n=120/503] [n=5/101]
aFrom 100 reports of 133,175 patients with diarrhea and 6,223
controls. bRanges given in parentheses. cData from reference (7).
Figure. Prevalence of IgG antibodies to Cryptosporidium
parvum, by age, in Brazil, China, and the United States.
<6m 6-11m 1y 2-4y 5-7y 8-10y 11-13y 14-16y 17-29y
0
20
40
60
80
100
120
Age
Brazil China U.S.
P
r
e
v
a
l
e
n
c
e
 
r
a
t
e
 
(
%
)53 Vol. 3, No. 1—January-March 1997 Emerging Infectious Diseases
Synopses
cases, other symptoms such as abdominal pain,
low-grade fever, and vomiting were not infrequent;
75% of infected nonimmunocompromised persons
had an average 10-lb weight loss.
Additional outbreaks involving public swim-
ming pools and wade pools have further docu-
mented the ability of Cryptosporidium to cause
infection even when ingested in relatively small
amounts of fully chlorinated water (22-26). While
the leading causes of 129 drinking and recrea-
tional water outbreaks in the United States from
1991 through 1994 were Giardia and Cryptospori-
dium, cryptosporidiosis accounted for substantially
more cases (even if the Milwaukee outbreak were
excluded) (23,24,26). In addition, although Crypto-
sporidium oocysts cannot multiply in the environ-
ment, an outbreak of foodborne cryptosporidiosis,
affecting 54% of those ingesting incriminated
freshly pressed apple cider, has been reported (27).
In this outbreak, Cryptosporidium oocysts were
found in the cider press, as well as in a calf on the
farm from which the apples were obtained. There
was also a 15% secondary attack rate in house-
holds involved in this outbreak. The apparent
person-to-person spread in households and institu-
tions such as day-care centers and hospitals
further documents the highly infectious nature of
Cryptosporidium. In an urban slum area in
northeastern Brazil, secondary household infections
occurred in 58% of households with an infected
child (index case) despite the 95% prevalence of
antibody in children more than 2 years of age (28).
The spread of cryptosporidiosis in day-care
centers is well documented, with 14 outbreaks
reported in the United States, as well as others in
the United Kingdom, France, Portugal, Australia,
Chile, and South Africa (29). Illnesses usually
occurred in the summer and early fall, especially
during August and September in the United States
and Portugal. Attack rates were 13% to 90%, with
the highest rates found among nontoilet-trained
toddlers and staff caring for children in diapers.
Overall prevalence rates were usually in the 1.8% to
3.8% range; however, rates as high as 30% in day-
care homes were reported (30). During outbreaks,
3.7% to 22.9% of infected children may not have
diarrhea; infectious oocysts may be excreted for
up to 5 weeks after diarrheal illness ends (31). In
addition, numerous nosocomial outbreaks of
cryptosporidiosis have occurred among health-
care workers as well as patients in bone marrow
transplant units, pediatric hospitals, and patient
wards with HIV-infected patients (32-37). Further-
more, elderly hospitalized patients may also be at
risk for Cryptosporidium infection (38). In one
Pennsylvania hospital, 45% of nurses, medical stu-
dents, and house staff caring for an HIV-positive
patient with cryptosporidiosis seroconverted (39).
Numerous potential animal and water sources
have been found to be infected with Crypto-
sporidium. In the Gonçalves Dias slum in Forta-
leza, Brazil, 10% of animals (including dogs, pigs,
donkeys, and goats), 6.3% during the dry season
to 14.3% during the wet season, had Cryptospori-
dium in their stool specimens. In addition, 22% of
drinking water sources studied were infected
with Cryptosporidium oocysts (40). Furthermore,
LeChavalier et al. have documented that Crypto-
sporidium oocysts were present in 27% of 66 drink-
ing water samples obtained from 14 states and one
Canadian province (mean of 0.18 NTU) (41,42).
Pathogenesis and Impact
C. parvum does not infect tissue beyond the
most superficial surface of the intestinal epithe-
lium; however, it can derange intestinal function.
Although a parasite enterotoxin has been exten-
sively sought and some reports have suggested
that one may exist (43), this issue remains contro-
versial, and the source of substances in the stools
of infected animals and patients that induce
secretion remains unclear (44). Extensive studies
in a piglet model of cryptosporidiosis by Argenzio
and colleagues demonstrate the loss of vacuolated
villus tip epithelium (approximately two-thirds
of the villus surface area), accompanied by an
approximate 50% reduction in glucose-coupled
sodium cotransport. What remains is a predomi-
nance of transitional junctional epithelium, in
which increased glutamine metabolism drives a
sodium-hydrogen exchange, to which is coupled
chloride transport. Thus, glutamine drives neutral
Table 2. Symptoms of 205 patients with confirmed cases
of cryptosporidiosis during the Milwaukee outbreaka
Symptom Percent(%)
Watery diarrhea 93
mean=12d; med=9d (1-55d)
mean=19/d; med=12/d (1-90)
39% recurred after 2d free
Abdominal cramps 84
Weight loss 75
(med=10lb, 1-40lb)
Fever 57
(med=38.3°, 37.2°-40.5°)
Vomiting 48
aData from reference (21)54 Emerging Infectious Diseases Vol. 3, No. 1—January-March 1997
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sodium chloride absorption in an apparent
prostaglandin-inhibitable manner in Cryptospori-
dium-infected piglet epithelium (45). Furthermore,
Argenzio and colleagues have demonstrated
increased macrophages that produce increased
tumor necrosis factor (TNF) in the lamina propria
of Cryptosporidium-infected piglets (46). Although
TNF did not directly affect epithelial transport,
when a fibroblast monolayer was added, an indo-
methacin-inhibitable secretory effect was noted
with TNF (46). Consequently, the researchers pro-
pose a prostaglandin-dependent secretory effect,
which occurs 1) through a bumetanide-inhibitable
chloride secretory pathway, predominantly from
crypt cells; and 2) through the inhibition of neu-
tral sodium chloride absorption through the
amiloride-sensitive sodium:hydrogen exchanger,
predominantly in the junctional or transitional
epithelium during active cryptosporidial infection.
Reduced xylose and B-12 absorption are among
the effects described in humans and animals with
cryptosporidiosis (47-49). Disruption of intestinal
barrier function with strikingly increased lactulose
to mannitol permeability and absorption has been
documented during active symptomatic crypto-
sporidial infection in children and in HIV-infected
adults (Lima et al., unpublished observations) (50).
Cryptosporidium appears to be one of the
leading causes of diarrhea, especially persistent
diarrhea, among children in northeastern Brazil
(51,52). In addition, the incidence of diarrhea has
been nearly double for many months in young
children after symptomatic cryptosporidial infec-
tions, suggesting that the disrupted barrier func-
tion in infected children leaves residual damage
resulting in increased susceptibility of injured
epithelium to additional diarrheal illnesses
(Agnew et al., unpub. obs.).
Recognition and Diagnosis
The diagnosis of C. parvum in patients with
diarrhea is usually made by using acid-fast or
immunofluorescence staining on unconcentrated
fecal smears. Appropriate concentration methods
may enhance detection when small numbers of
oocysts are present, but some methods such as
formalin-ethyl acetate concentration may result
in loss of many oocysts (52,53). While several
enzyme-linked immunosorbent assay methods
are available for detection of fecal cryptosporidial
antigen with 83% to 95% sensitivity in diarrheal
specimens, these methods are less sensitive in
formed specimens and require more time. Micro-
scopy using immunofluorescence antibody is
slightly more sensitive and may be faster (54,55).
Polymerase chain reaction (PCR) provides a
new method that may help detect Cryptospori-
dium in water supplies or asymptomatic carriers.
A genomic DNA library has been constructed in
the plasmid pUC18 for propagation in Escherichia
coli. After sequencing a 2.3 kilobase C. parvum-
specific fragment, a 400-base sequence with a
unique Sty I site has been amplified by using
primers of 26 nucleotides each (56). Laxer et al.
then used a 20-base probe labeled with digoxigenin-
11-dUTP to detect C. parvum DNA in fixed, paraf-
fin-embedded tissue (57). In addition, primers for
a 556 BP Cryptosporidium-specific region of the
small subunit 18s ribosomal RNA gene have been
used to produce a PCR product with unique Mae 1
sites that distinguish C. parvum from C. baileyi and
C. muris (58). Available methods for detection of
viable oocysts in environmental samples are rela-
tively insensitive and under active investigation.
Treatment and Prevention
Despite numerous attempts at examining
transfer factor, hyperimmune colostral antibody,
and more than 100 antiparasitic and antimicrobial
agents, few agents have shown modest benefit in
controlled studies; paromomycin is one of them.
Although this agent does not eradicate the para-
site in immunocompromised patients, it slightly
reduces parasite numbers (from 314 x 106 to 109 x 106
oocysts shed per day) and decreases stool fre-
quency, with a tendency toward improved Karnof-
sky scores and reduced stool weight (59). In view
of its effectiveness in driving sodium cotransport
(60) and its success in studies of experimental
animals, we are examining a new approach to
speeding repair of disrupted intestinal barrier
function by using glutamine and its derivatives.
The ability of the thick-walled oocysts to
persist and spread in the environment and their
well-documented resistance to chlorine are respon-
sible for the spread of Cryptosporidium even in
fully chlorinated water supplies that meet existing
turbidity standards in drinking water and swim-
ming pools. Although some scientists have noted
that 9,600 parts per million (mg/l) of chlorine for
one minute of exposure are required to decontami-
nate water (14), others have noted that even after
exposure to full-strength household bleach (5.25%
sodium hypochlorite; 50,000 parts per million) for55 Vol. 3, No. 1—January-March 1997 Emerging Infectious Diseases
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2 hours, the oocysts still remained infectious for
experimental animals (15). While Giardia are 14
to 30 times more susceptible to chlorine dioxide
or ozone, respectively, ozone is probably the most
effective chemical means of inactivating Crypto-
sporidium oocysts (16). Consequently, eradication
of the organism from drinking water supplies
depends on adequate flocculation and filtration,
rather than chlorination. Although previous
turbidity requirements were based on the removal
of larger parasite cysts  such as those of Giardia
lamblia or Entamoeba histolytica, the smaller C.
parvum oocysts are more difficult to remove.
Several waterborne outbreaks, including the
recent outbreak in Milwaukee, have occurred
with turbidity levels in the 0.45 to 1.7 nephelo-
metry turbidity units (NTU) range. In a study of
waterborne cryptosporidiosis, predominantly among
HIV-positive adults in Clark County, Nevada,
Goldstein et al. (1996) report that the outbreak was
associated with a substantial number of deaths
and that the turbidity of the implicated water never
exceeded 0.17 NTU (much lower than the new stan-
dard of 0.5 NTU required for 95% of measure-
ments each month, with no spikes over 1.0 NTU) (5).
New approaches to the eradication of infectious
oocysts from water supplies are needed, possibly
using reverse osmosis, membrane filtration, or
electronic or radiation methods, instead of the
ineffective chemical or difficult filtration techniques
currently used. Ideally, these new methods would
provide low cost, effective treatment that could
be applied in developing areas as well. Mean-
while, an improved understanding of the patho-
genesis and impact of Cryptosporidium infections
should aid the development of improved treatment
and control of this ubiquitous, highly infectious
threat to the water supply and to the people it
serves, especially malnourished children and
immunocompromised patients around the world.
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